Archil Shartava
University of South Alabama
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Archil Shartava.
American Journal of Hematology | 1997
Archil Shartava; William Korn; Arvind K. Shah; Steven R. Goodman
It has been demonstrated that cysteine modification in irreversibly sickled cell β‐actin slows down the remodeling of membrane skeletons [Shartava et al.: J Cell Biol 128:805‐812, 1995]. This slow remodeling can be due to alterations in spectrin‐actin binding and/or actin‐actin interactions in irreversibly sickled cell (ISC) membrane skeletons. In these studies we demonstrate that ISC actin binds spectrin normally. However, ISC β‐actin polymerizes and depolymerizes more slowly than control β‐actin, and forms unusual aggregates when placed under polymerizing conditions. Electron microscopic analysis of actin polymers indicated that ISC actin generates a large amount of aggregates which we conclude are due to the structural modification caused by the disulfide bridge between cysteine264 and cysteine373 in β‐actin. Am. J. Hematol. 55:97‐103, 1997.
American Journal of Hematology | 2000
Archil Shartava; Jonah McIntyre; Arvind K. Shah; Steven R. Goodman
The red blood cells (RBCs) derived from blood taken from homozygous sickle cell (SS) patients demonstrate densities that are inversely proportional to the intracellular reduced glutathione (GSH) content. Addition of 1 mM 1‐chloro‐2,4‐dinitrobenzene (CDNB) to low‐density sickle cells (LDSS), at 4°C, results in a shift of LDSS erythrocytes to high‐density sickle cells (HDSS), with corresponding decreases in GSH. We have previously demonstrated that this CDNB effect was due to increased K+ leakage and that dense cell formation could be inhibited by clotrimazole (specific for the Gardos channel) but not DIOA (specific for the K+–Cl− co‐transport system) at pH 7.4 (Shartava et al. Am. J. Hematol. 1999;62:19–24). Here we demonstrate that clotrimazole (10 μM) inhibits dense cell formation at pH 7.1 and 6.8, while DIOA (1 mM) has no effect. As pH 6.8 is the optimal pH for the K+–Cl− co‐transport system, we can now reasonably conclude that damage to the Gardos channel is responsible for CDNB‐induced dense cell formation. Am. J. Hematol. 64:184–189, 2000.
American Journal of Hematology | 1998
Carlos A. Monteiro; Xunda A. Gibson; Archil Shartava; Steven R. Goodman
We have identified a rabbit autoantibody that strongly reacts with the core membrane skeleton of control red blood cells, and does not react with low‐ or high‐density sickle cell core skeletons upon indirect immunofluorescence. Western blot analysis of red blood cell membrane proteins, utilizing this autoantibody, indicated no reactivity to any protein when SDS‐PAGE was conducted in the presence of the reducing agent, dithiothreitol. However when SDS‐PAGE was performed on control red blood cell membrane proteins separated in the absence of dithiothreitol, the autoantibody specifically reacted with a high molecular weight polypeptide (apparent Mr ≊ 310 kD) representing a DTT sensitive form of control α spectrin, which we refer to as α/ spectrin. There was no staining of high density or low density sickle cell α or α/ spectrin. This autoantibody should be an excellent tool for the fine mapping of structural change(s) in control vs. sickle cell α spectrin, and determination of whether the structural alteration effects spectrin dimer‐tetramer interconversion and/or the spectrin‐actin interaction. The modification in α spectrin, detected by this antibody, is very specific for homozygous SS α spectrin because sickle cell β+ thalassemic α spectrin and sickle cell trait α spectrin react intensely with the autoantibody. Am. J. Hematol. 58:200–205, 1998.
American Journal of Hematology | 2003
Betty S. Pace; Archil Shartava; Ardie Pack‐Mabien; Mudhari Mulekar; Alfredo Ardia; Steven R. Goodman
Blood | 1998
Xunda A. Gibson; Archil Shartava; Jonah McIntyre; Carlos A. Monteiro; Yalin Zhang; Arvind K. Shah; Naomi F. Campbell; Steven R. Goodman
Journal of Cell Biology | 1995
Archil Shartava; Carlos A. Monteiro; F. Aladar Bencsath; Klaus Schneider; Brian T. Chait; Rick Gussio; Linda A. Casoria-Scott; Arvind K. Shah; Christine A. Heuerman; Steven R. Goodman
Biochemistry | 2002
Ann Abraham; F. Aladar Bencsath; Archil Shartava; David Kakhniashvili; Steven R. Goodman
American Journal of Hematology | 1996
Archil Shartava; Paul Miranda; Kenya N. Williams; Arvind K. Shah; Carlos A. Monteiro; Steven R. Goodman
Archive | 2000
Archil Shartava
Archive | 2013
F. Campbell; Steven R. Goodman; Xunda A. Gibson; Archil Shartava; Jonah McIntyre; Carlos A. Monteiro; Yalin Zhang; Arvind K. Shah